Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma. [electronic resource]
Producer: 20190912Description: 300-305 p. digitalISSN:- 1537-4513
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Squamous Cell -- immunology
- Chemoradiotherapy
- Cyclin-Dependent Kinase Inhibitor p16 -- genetics
- Drug Resistance, Neoplasm
- Fatal Outcome
- Humans
- Immunotherapy -- methods
- Lymphocytes, Tumor-Infiltrating -- immunology
- Male
- Middle Aged
- Mutation -- genetics
- Neoplasm Staging
- Nivolumab -- therapeutic use
- Penile Neoplasms -- immunology
- Programmed Cell Death 1 Receptor -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Tumor Burden
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.